analyst
TR
NASDAQ · TRVI
Trevi Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$15.90
Down-$0.01 (-0.06%)
Updated Sep 12, 2026, 6:38 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.69B
- P/E ratio
- -41.7
- Dividend yield
- 0.00%
- 52-week range
- $10.25 – $20.22
- Volume
- 2.02M
- Avg. volume
- 1.99M
Price performance
TRVI price history
1M range · 20 trading sessions · Daily adjusted prices
TRVI closed at $15.90 after 20 trading sessions, down 13.87% for the selected period.
- Last close
- $15.90
- Period change
- -13.87%
- Period low
- $15.90
- Period high
- $18.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $16.20 | $16.57 | $15.87 | $15.90 | 2.02M |
| Sep 10, 2026 | $16.51 | $16.51 | $15.71 | $15.91 | 1.25M |
| Sep 9, 2026 | $16.87 | $17.025 | $16.51 | $16.64 | 959.54K |
| Sep 8, 2026 | $16.94 | $17.18 | $16.59 | $16.82 | 1.49M |
| Sep 4, 2026 | $16.88 | $17.315 | $16.80 | $17.26 | 856.67K |
| Sep 3, 2026 | $17.09 | $17.15 | $16.47 | $17.06 | 1.43M |
| Sep 2, 2026 | $16.57 | $17.115 | $16.22 | $17.05 | 1.35M |
| Sep 1, 2026 | $16.40 | $16.73 | $16.32 | $16.57 | 945.06K |
| Aug 31, 2026 | $16.66 | $16.735 | $16.0803 | $16.60 | 1.87M |
| Aug 28, 2026 | $17.88 | $18.0899 | $16.625 | $16.79 | 1.97M |
| Aug 27, 2026 | $17.85 | $18.105 | $17.61 | $17.96 | 1.23M |
| Aug 26, 2026 | $17.89 | $18.005 | $17.42 | $17.92 | 1.21M |
| Aug 25, 2026 | $18.29 | $18.59 | $17.69 | $17.95 | 2.14M |
| Aug 24, 2026 | $17.855 | $18.125 | $17.24 | $18.08 | 1.23M |
| Aug 21, 2026 | $18.44 | $18.54 | $17.83 | $17.96 | 1.14M |
| Aug 20, 2026 | $18.59 | $18.99 | $18.15 | $18.25 | 1.25M |
| Aug 19, 2026 | $19.29 | $19.30 | $18.50 | $18.81 | 1.98M |
| Aug 18, 2026 | $18.46 | $18.97 | $18.18 | $18.84 | 1.75M |
| Aug 17, 2026 | $18.26 | $18.57 | $18.17 | $18.48 | 867.38K |
| Aug 14, 2026 | $17.98 | $18.54 | $17.63 | $18.46 | 1.39M |
Latest TRVI news
The latest Smart Investors Daily articles mentioning TRVI.
Stock researchResearch & News · SEC Filings
Loading stock research…